CHE logo

Chemed (CHE)

Profile

Full Name

Chemed Corporation

Ticker Symbol

CHE

Exchange

NYSE

Sector

Healthcare

Industry

Medical Care Facilities

Country

United States

IPO

May 3, 1973

Indexes

Not included

Website

http://www.chemed.com

Employees

15695

Key Details

Price

$486.93(-12.95%)

Market cap

$7.12B(Mid cap)

Last Dividend

$0.50

TTM Dividend yield

0.41%

Annual revenue

$2.43B(+7.37% YoY)

Annual EPS

$19.89(+10.93% YoY)

PE ratio

23.72

Next earnings date

Jul 24, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $486.93
    CHE price is $486.93

    30-Day Relative Volume

    4.78
    CHE 30-day relative volume is 4.78

    Price Performance

    Price Today change

    -12.95%
    CHE price is down -12.95% today

    Price YTD change

    -8.09%
    CHE price is down -8.09% since January 1st

    Price 1-year change

    -10.26%
    CHE price is down -10.26% year-on-year

    Price 3-year change

    +3.74%
    CHE price is up +3.74% over the past 3 years

    Price Range

    Price All-time high

    $654.62
    CHE price is currently -25.62% below its historical high of $654.62

    Price 3-year low

    $430.16
    CHE price is currently +13.20% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $7.12B
    CHE market capitalization is $7.12 billion

    Market cap 3-year change

    +1.82%
    CHE market capitalization is up +1.82% over the past 3 years

    Market cap All-time high

    $9.83B
    CHE market capitalization is currently -27.55% below its historical high of $9.83 billion

    Market cap sector rank

    90.92%
    CHE market capitalization is higher than 90.92% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -3.02%
    CHE shares outstanding is down -3.02% year-on-year

    Shares Outstanding 3-Year Change

    -2.26%
    CHE shares outstanding is down -2.26% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.29
    CHE beta is 0.29

    200-day SMA

    $568.50
    CHE price is currently -14.35% below its 200-day simple moving average

    50-day SMA

    $563.77
    CHE price is currently -13.63% below its 50-day simple moving average

    RSI

    23.22
    CHE 14-day relative strength index is 23.22

    Volume

    4.78
    CHE 30-day relative volume is 4.78

    ATR

    $14.67
    CHE average true range is $14.67

    10-day Historical Volatility

    67.19%
    CHE 10-day historical volatility is 67.19%

    Dividend

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Events

    Last Paid Dividend

    $0.50
    CHE last dividend was $0.50 per share, with an ex-dividend date of May 29, 2025

    Next Dividend

    -
    CHE next dividend has not yet been announced

    Dividend per share

    Dividend per share

    $1.80
    CHE annual dividend per share is $1.80

    Dividend per share Sector Rank

    65.88%
    CHE annual dividend per share is higher than 65.88% of companies in Healthcare sector

    Dividend per share 1-Year Change

    +15.38%
    CHE annual dividend per share is up +15.38% year-on-year

    Dividend per share 3-Year Change

    +28.57%
    CHE annual dividend per share is up +28.57% over the past 3 years

    Dividend yield

    Dividend yield

    0.37%
    CHE annual dividend yield is 0.37%

    Dividend yield Sector Rank

    8.33%
    CHE annual dividend yield is higher than 8.33% of companies in Healthcare sector

    Other

    Payout ratio

    8.97%
    CHE annual payout ratio is 8.97%

    Dividends paid

    $27.09M
    CHE annual dividends paid is $27.09 million

    Free cash flow

    $367.97M
    CHE annual free cash flow is $367.97 million

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $2.43B
    CHE annual revenue is $2.43 billion

    Revenue Analysts estimate

    $2.64B
    CHE annual revenue is currently -7.79% lower than the consensus analysts' forecast

    Revenue 1-year change

    +7.37%
    CHE annual revenue is up +7.37% year-on-year

    Revenue Sector rank

    86.43%
    CHE annual revenue is higher than 86.43% of companies in Healthcare sector

    EPS

    EPS

    $19.89
    CHE annual earnings per share is $19.89

    EPS Analysts estimate

    $25.28
    CHE annual earnings per share is currently -21.32% lower than the consensus analysts' forecast

    EPS 1-year change

    +10.93%
    CHE annual earnings per share is up +10.93% year-on-year

    EPS Sector rank

    99.09%
    CHE annual earnings per share is higher than 99.09% of companies in Healthcare sector

    Profit

    Gross profit

    $854.35M
    CHE annual gross profit is $854.35 million

    Gross margin

    35.14%
    CHE annual gross profit margin is 35.14%

    Operating profit

    $366.94M
    CHE annual operating income is $366.94 million

    Operating margin

    15.09%
    CHE annual operating profit margin is 15.09%

    Net income

    $302.00M
    CHE annual net profit is $302.00 million

    Net margin

    12.42%
    CHE annual net profit margin is 12.42%

    Expenses

    Total expenses

    $2.06B
    CHE annual total expenses is $2.06 billion

    Operating expenses

    $487.41M
    CHE annual total operating expenses is $487.41 million

    Cost of goods sold

    $1.58B
    CHE annual cost of goods sold is $1.58 billion

    Selling, general & administrative expenses

    $424.36M
    CHE annual SGA is $424.36 million

    Depreciation and amortization

    $63.05M
    CHE annual depreciation & amortization is $63.05 million

    Interest expense

    $1.78M
    CHE annual interest expense is $1.78 million

    Income tax

    $97.47M
    CHE annual income tax is $97.47 million

    EBIT & EBITDA

    EBIT

    $401.25M
    CHE annual earnings before interest & taxes is $401.25 million

    EBITDA

    $464.29M
    CHE annual EBITDA is $464.29 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $1.67B
    CHE annual total assets is $1.67 billion

    Non current assets

    $1.27B
    CHE annual long term assets is $1.27 billion

    Current assets

    $394.75M
    CHE annual total current assets is $394.75 million

    Cash and cash equivalents

    $178.35M
    CHE annual cash & cash equivalents is $178.35 million

    Accounts receivable

    $171.16M
    CHE annual accounts receivable is $171.16 million

    Inventory

    $8.19M
    CHE annual inventory is $8.19 million

    Liabilities

    Total liabilities

    $549.58M
    CHE annual total liabilities is $549.58 million

    Long term liabilities

    $263.89M
    CHE annual total long term liabilities is $263.89 million

    Current liabilities

    $285.69M
    CHE annual total current liabilities is $285.69 million

    Accounts payable

    $44.15M
    CHE annual accounts payable is $44.15 million

    Debt

    Total debt

    $140.84M
    CHE annual total debt is $140.84 million

    Total debt 1-year change

    +1.03%
    CHE annual total debt is up +1.03% year-on-year

    Long term debt

    $98.54M
    CHE annual long term debt is $98.54 million

    Short term debt

    $42.31M
    CHE annual short term debt is $42.31 million

    Equity & Capital

    Shareholders equity

    $1.12B
    CHE annual stockholders equity is $1.12 billion

    Book value

    $1.12B
    CHE annual book value is $1.12 billion

    Retained earnings

    $2.72B
    CHE annual retained earnings is $2.72 billion

    Working capital

    $109.05M
    CHE annual working capital is $109.05 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $417.50M
    CHE annual cash flow from operations is $417.50 million

    Cash from operations 1-year change

    +26.4%
    CHE annual cash flow from operations is up +26.4% year-on-year

    Cash from investing

    -$143.91M
    CHE annual cash flow from investing activities is -$143.91 million

    Cash from investing 1-year change

    -137.31%
    CHE annual cash flow from investing activities is down -137.31% year-on-year

    Cash from financing

    -$359.19M
    CHE annual cash flow from financing activities is -$359.19 million

    Cash from financing 1-year change

    -349.98%
    CHE annual cash flow from financing activities is down -349.98% year-on-year

    CAPEX

    CAPEX

    $49.53M
    CHE annual capital expenditures is $49.53 million

    CAPEX 1-year change

    -12.88%
    CHE annual capital expenditures is down -12.88% year-on-year

    Free Cash Flow

    Free cash flow

    $367.97M
    CHE annual free cash flow is $367.97 million

    Free cash flow 1-year change

    +34.57%
    CHE annual free cash flow is up +34.57% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    35.14%
    CHE annual gross profit margin is 35.14%

    Operating margin

    15.09%
    CHE annual operating profit margin is 15.09%

    Net margin

    12.42%
    CHE annual net profit margin is 12.42%

    ROA & ROE

    ROA

    18.10%
    CHE annual return on assets is 18.10%

    ROE

    27.12%
    CHE annual return on equity is 27.12%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    23.72
    CHE price to earnings ratio is 23.72

    PE ratio Sector rank

    48.13%
    CHE price to earnings ratio is higher than 48.13% of companies in Healthcare sector

    PB Ratio

    PB ratio

    6.03
    CHE price to book ratio is 6.03

    PB ratio Sector rank

    83.87%
    CHE price to book ratio is higher than 83.87% of companies in Healthcare sector

    PS Ratio

    PS ratio

    2.86
    CHE price to sales ratio is 2.86

    PS ratio Sector rank

    50.33%
    CHE price to sales ratio is higher than 50.33% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $7.09B
    CHE enterprise value is $7.09 billion

    Enterprise value Sector rank

    90.02%
    CHE enterprise value is higher than 90.02% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    14.92
    CHE EV/EBITDA is 14.92

    EV/EBITDA Sector rank

    88.51%
    CHE EV/EBITDA is higher than 88.51% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.38
    CHE annual current ratio is 1.38

    Quick ratio

    1.35
    CHE annual quick ratio is 1.35

    Leverage

    Debt to equity

    0.00
    CHE annual debt to equity ratio is 0.00

    Interest coverage ratio

    225.42
    CHE annual interest coverage ratio is 225.42

    Risk & Stability

    Piotroski F-Score

    7
    CHE piotroski f-score is 7

    Altman Z-Score

    12.39
    CHE altman z-score is 12.39

    Analyst ratings

    Recent major analysts updates

    Apr 28, 25 RBC Capital
    Outperform
    Mar 14, 25 RBC Capital
    Outperform
    Nov 5, 24 RBC Capital
    Outperform
    May 21, 24 RBC Capital
    Outperform
    Mar 4, 24 RBC Capital
    Outperform
    Feb 29, 24 Oppenheimer
    Outperform
    Jan 17, 24 Oppenheimer
    Outperform
    Oct 30, 23 RBC Capital
    Outperform
    Jul 31, 23 RBC Capital
    Outperform
    Jul 27, 23 Oppenheimer
    Outperform

    Institutional Ownership

    Screeners with CHE included

    Mid cap stocks
    US stocks
    High Piotroski score stocks
    Stocks below SMA 200
    Most recommended stocks
    Stocks below analysts price target
    Healthcare sector
    Companies with growing dividends
    All stocks
    High Altman Z score stocks
    • What is the ticker symbol for Chemed?
    • Does Chemed pay dividends?
    • What sector is Chemed in?
    • What industry is Chemed in?
    • What country is Chemed based in?
    • When did Chemed go public?
    • Is Chemed in the S&P 500?
    • Is Chemed in the NASDAQ 100?
    • Is Chemed in the Dow Jones?
    • When was Chemed's last earnings report?
    • When does Chemed report earnings?
    • Should I buy Chemed stock now?

    What is the ticker symbol for Chemed?

    The ticker symbol for Chemed is NYSE:CHE

    Does Chemed pay dividends?

    Yes, Chemed pays dividends. The last payment was $0.50, with an ex-dividend date on May 29, 2025

    What sector is Chemed in?

    Chemed is in the Healthcare sector

    What industry is Chemed in?

    Chemed is in the Medical Care Facilities industry

    What country is Chemed based in?

    Chemed is headquartered in United States

    When did Chemed go public?

    Chemed's initial public offering (IPO) was on May 3, 1973

    Is Chemed in the S&P 500?

    No, Chemed is not included in the S&P 500 index

    Is Chemed in the NASDAQ 100?

    No, Chemed is not included in the NASDAQ 100 index

    Is Chemed in the Dow Jones?

    No, Chemed is not included in the Dow Jones index

    When was Chemed's last earnings report?

    Chemed's most recent earnings report was on Apr 23, 2025

    When does Chemed report earnings?

    The next expected earnings date for Chemed is Jul 24, 2025

    Should I buy Chemed stock now?

    As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page